You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Pulmonology

ADVENT at ERS 2024

The ADVENT program will present four symposia sharing the latest science in asthma and COPD at the European Respiratory Society Congress 2024. Visit Booth #A4.02 to learn more about ADVENT.

MD, PhD, FERS

Klaus Rabe +7 more

Past event

7September2024

Location

Messe Wien Exhibition Congress Center

Messepl. 1, 1020 Vienna Austria

Symposium Details

September 9

Biologic Therapy for Pediatric Severe Asthma: Is Clinical Remission Possible?

Join Len Bacharier, MD, and Sharon Dell, MD, FRCPC, for an educational symposium on the concept of clinical remission in pediatric severe asthma.

September 9

A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz, Mona Bafadhel, and Alberto Papi for an educational symposium on the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden, exploring the role of type 2 cytokines, and current and emerging therapies.

September 9

Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

September 10

Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Engage with experts Klaus Rabe, Stephanie Christenson, and Paola Rogliani in an educational symposium to explore the inflammatory pathways and phenotypes of COPD, investigate the genetic associations of IL-33 and COPD, examine early preclinical findings, and review ongoing research on the role of IL-33 in COPD.

Location

Messe Wien Exhibition Congress Center

Messepl. 1, 1020 Vienna Austria

Speakers

Pulmonology

MD, PhD, FERS

Klaus Rabe

Professor of Pulmonary Medicine | University of Kiel; Director of the Department of Pneumology | LungClinic Grosshansdorf, Kiel, Germany

Pulmonology

MD, PhD

Celeste Porsbjerg

Professor of Severe Asthma, Bispebjerg Hospital Copenhagen, Denmark

Pulmonology

MD, MPH

Mario Castro

Chief, Pulmonary, Critical Care and Sleep Medicine; Vice Chair for Clinical and Translational Research, University of Kansas School of Medicine

Allergy/Immunology

Leonard Bacharier

Janie Robinson and John Moore Lee Chair of Pediatrics and Director of Center for Pediatric Asthma Research | Vanderbilt University, Tennessee, United States

Pulmonology

MD, FRCPC

Sharon Dell

Professor and Head of the Division of Respiratory Medicine in the Department of Pediatrics | University of British Columbia, Canada

Pulmonology

MD, PhD

Alberto Papi

Professor of Respiratory Medicine | University of Ferrara; Director of the Respiratory Unit of the Department of Emergency Medicine | Saint Anna University Hospital, Ferrara, Italy

Pulmonology

MD, PhD

Henrik Watz

Professor, University of Kiel, Kiel, Germany | Medical Director, Velocity Clinical Research Grosshansdorf, Grosshansdorf, Germany

Pulmonology

MD, PhD

Mona Bafadhel

Chair of Respiratory Medicine Director of the King’s Centre for Lung Health

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region